Literature DB >> 6328169

Intracerebral beta-endorphin, met-enkephalin and morphine: kindling of seizures and handling-induced potentiation of epileptiform effects.

D P Cain, M E Corcoran.   

Abstract

The effects of repeated infusion of small, initially subconvulsive amounts of beta-endorphin, met-enkephalin or morphine sulfate into the amygdala and hippocampus were investigated. beta-endorphin and met-enkephalin evoked epileptiform spiking when infused into the posterior amygdala or ventral hippocampus. Morphine evoked epileptiform spiking when infused into the anterior amygdala. Naloxone blocked or terminated the spiking. Repetition of the infusions led to the gradual development of bilateral generalized convulsions by beta-endorphin and met-enkephalin and to the development of tolerance to morphine. An unexpected observation was that handling, immobilization or conspecific threat potentiated the epileptiform effects of beta-endorphin and morphine in many cases. These results suggest that endogenous opiate mechanisms might play a role in convulsive seizures and that stressful stimuli can exacerbate opiate seizures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6328169     DOI: 10.1016/0024-3205(84)90291-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  Adult neurogenesis in the mouse dentate gyrus protects the hippocampus from neuronal injury following severe seizures.

Authors:  Swati Jain; John J LaFrancois; Justin J Botterill; David Alcantara-Gonzalez; Helen E Scharfman
Journal:  Hippocampus       Date:  2019-01-23       Impact factor: 3.899

2.  Accelerated kindling development in mu-opioid receptor deficient mice.

Authors:  G Grecksch; A Becker; H Schroeder; J Kraus; H Loh; V Höllt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-12       Impact factor: 3.000

3.  Activation of amygdala opioid receptors by electroacupuncture of Feng-Chi (GB20) acupoints exacerbates focal epilepsy.

Authors:  Pei-Lu Yi; Chin-Yu Lu; Chiung-Hsiang Cheng; Yi-Fong Tsai; Chung-Tien Lin; Fang-Chia Chang
Journal:  BMC Complement Altern Med       Date:  2013-10-29       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.